Sabitlenmiş Tweet
"This brought me hope,” a PRIMA patient said. “It literally changed my life.”
TIME@TIME
If you already feel like we’re living in a sci-fi movie, buckle up. Brain and retinal chips are coming time.com/7330887/brain-…
English
Science Corporation
90 posts
Science Corporation
@ScienceCorp_
Building a brighter tomorrow enabled by neural engineering
Katılım Temmuz 2025
1 Takip Edilen2.3K Takipçiler
“It’s the first time that any attempt at vision restoration has achieved such results in a large number of patients… This is really something we couldn’t have dreamt of when we started on this journey more than two decades ago.”
In a new interview, José-Alain Sahel, MD, a senior author of the PRIMA clinical trial now published in @NEJM, shares his opinion on the resilience required to turn a decades-old concept into clinical reality.
English
"...we have three programs at Science: our work in the retina [for blindness]...our biohybrid neural interface…and critical care life support”, shared Max Hodak, Science’s CEO. “If Medtronic was started in 2021, what are the projects that they would be taking on for the next 20 years?”
English
Science Corporation retweetledi
YC alum Max Hodak is building brain computer interfaces that actually work
Y Combinator@ycombinator
Max Hodak (@maxhodak_) is the co-founder of Neuralink and founder of @ScienceCorp_, a company building brain-computer interfaces that can restore sight. Science has developed a tiny retinal implant that stimulates cells in the eye to help blind patients see again. More than 40 patients have already received the treatment in clinical trials, including one who recently read a full novel for the first time in over a decade. In this episode of How to Build the Future, Max joined @garrytan to discuss how BCIs work, what it takes to engineer the brain, and why brain-computer interfaces may become one of the most important technologies of the next decade. 00:26 — The retinal chip helping blind patients see 01:51 — What brain-computer interfaces really are 03:37 — Could BCIs enhance intelligence? 05:44 — The brain’s incredible plasticity 09:23 — What it feels like to see with an implant 13:01 — Can we restore full human vision? 17:55 — Is the brain basically a computer? 24:59 — Max Hodak’s path into brain tech 28:57 — How Neuralink actually started 33:10 — How the brain represents information 39:47 — Bio-hybrid brain interfaces 44:32 — Building the company Science 51:27 — The future of BCIs and human longevity
English
"I think that BCI is not a specific product, I think there's going to be a bunch of BCI companies going after different applications where different types of probes will make sense. To me, it firmly feels like we're in the takeoff era."
Science founder and CEO @maxhodak_ joined @ycombinator to talk about the future of brain-computer interfaces.
English
Join the Science Patient Registry at patients.science.xyz
English
Science's PRIMA clinical trials are expanding to Australia, and will include inherited retinal diseases, such as Stargardt disease and retinitis pigmentosa.
English
Science Corporation retweetledi
Science Corp. founder @maxhodak_ explains how their visual prosthesis actually works to help restore vision:
"The device that we have now is 2mm by 2mm... it's like looking through a straw. The electrodes are 0.1mm, which means that you stimulate a bunch of cells at a time... and they only get a small amount of detail at once."
"We're not restoring high-resolution color vision today, but what we are getting is this intuitive-form image that patients can look at. It strings together shapes into letters and letters into words, and the brain can apprehend that intuitively. And that had never really been done before."
"We actually have the next version of the chips already in hand. The electrodes are much smaller and are going to go from 400 to a couple thousand. We're working on the clinical study for those over the next year. And hopefully every two years or so we'll have new versions coming out."
English
We’ve closed a $230 million Series C financing. The deal was oversubscribed with demand in excess of our capital needs, and brings the total capital invested into the company to approximately $490 million since our founding in 2021.
English
English
We’ve closed a $230 million Series C financing with participation from @khoslaventures, @lightspeedvp, @ycombinator, IQT, and @QuietCapital, all pre-existing investors in Science, among others.
English
Robots can place atoms with sub-micron precision, but nothing beats the human touch when it comes to handling live neural tissue.
Neurons grow long, delicate projections designed to be enmeshed in the dense structure of a brain. In a lab dish, they lack that structural scaffolding, making them incredibly vulnerable to fluid shear stress.
English
@josiezayner Our biohybrid BCI technology, which uses living neurons to connect to the brain instead of wires, circumvents the constraints of traditional neural interfaces and minimizes the damage done to the brain. Learn more here: science.xyz/technologies/b…
English
@ScienceCorp_ What is a biohybrid cell? Is it just a cell with graphene or CNTs or something?
English
@NeurosoftBio Read more here: science.xyz/news/neurosoft…
English
We have partnered with @NeurosoftBio, a neural data company developing ultra-soft, flexible neural probes to achieve full cortical coverage powering foundation AI models of the brain, to grant Neurosoft access to Science’s world-class clinical-grade neural engineering capabilities known as the Science Ecosystem.
English